Physician profile
Wei Wang
NPI 1184788523
$2,852.37
in general payments reported to CMS, 2019-2025
17 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $364 · 2021: $105 · 2022: $289 · 2023: $374 · 2024: $99.40 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $863.06 | 2019-2020 | |
| Gilead Sciences, INC. | $553.56 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $323.23 | 2019-2023 | Farxiga |
| Abbvie INC. | $243.45 | 2019-2023 | Creon |
| Glaxosmithkline, LLC. | $125.00 | 2025 | Shingrix |
| Corium, LLC | $125.00 | 2023 | Adlarity |
| Novo Nordisk INC | $125.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Radius Health, INC. | $114.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.91 | 2022-2023 | Jardiance |
| Biogen, INC. | $44.84 | 2020-2022 | |
| Coherus Oncology, INC. | $29.02 | 2025 | Loqtorzi |
| Bayer Healthcare Pharmaceuticals INC. | $25.06 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.00 | 2023 | Xifaxan, Trulance |
| Mirati Therapeutics, INC. | $23.81 | 2023 | Krazati |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $23.00 | 2020 | |
| Vifor Pharma, INC. | $21.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.